# data[].attributes.body
NUR353
Strategy Board
8-2-2016

# data[].attributes.body
* What are the evidence-based guidelines, position papers, patient safety initiatives, and published literature on CLABSI and its prevention?
* What CLABSI surveillance measures are used, benchmarking, and public reporting?
* What types of surveilance is needed?

# data[].attributes.headline
                 Prevention of Central Line Associated Blood Stream Infections:  SVS MICU

# data[].attributes.subject
                 Prevention of Central Line Associated Blood Stream Infections:  SVS MICU

# data[].attributes.body
* What hospitals are our competitors?
* What are types of central venous catheters and risk factors for and pathogenesis of CLABSIs
* What are CLABSI prevention strategies, techniques and technologies, and barriers to best practices •

* What is the acuity of the patient?
* Comorbities?
* Does the patient have a drug abuse history?

# data[].attributes.body
What are the costs?

* Cost assessments?
* Estimate average   amount of reimbursement loss?

*Education standards?

*Cost of new technology?

# data[].attributes.body
Operations Panel
What healthcare associates are participating in patient care?

*  Physicians, nurses, techs, radiology, lab, infectious disease, nutrition, pharmacy?

What standards need to be in place?·
* Are guidelines in place with prevention strategies for health care clinicians?
*  Is baseline data obtained?
*  Are reduction goals set in place?

*  Are  daily audits in place to assess whether the central line is needed any longer?

*  Are sterile technique practices being followed?

*  Are central lines being handled and maintained appropriately?
* Is monitoring in place to identify units and trends (if any) with known CLABSI during 2016?
* Has RN knowledge of CLABSI been assessed on all units?
* Is literature review available to ascertain best practice and identify opportunity to improve practice here at SVS?
* Is assessment in place to identify current (nursing) process for assisting MDs with central-line insertion?
* Is education available for hospital staff on CLABSI and the "bundle" used to minimize these infections.
* Is patient safety maintained at all times?

# data[].attributes.body
Target Market:

* Who is providing healthcare?

* Who needs to collaborate?

* Who needs education on CLABSI prevention?

# data[].attributes.body
Purpose:
Reduction in CLABSI (Central line associated blood stream infections) by 25% in the MICU SVS by December 31, 2016.

Mission: Empower, educate and prevent ClABSIs in the MICU.